Bryophyllum Pinnatum

Bryophyllum pinnatum  (Lam.) Kurz.

1. Taxonomic, Nomenclature & Therapeutic Summary Table

Botanical Attribute Pharmacognostic & Therapeutic Specification
Synonym B. calycinum Salisb. Kalanchoe pinnata Pers.
Family Crassulaceae.
Habitat Throughout the warm and moist parts of India, especially abundant in West Bengal.
Ayurvedic Parnabija, Airaavati. (Also known as Paashaanabheda.)
Unani Zakhm-e-Hayaat.
Action Leaf—disinfectant, antibacterial (used for boils, insect bites, swellings, burns, wounds).
Dosage Leaf—10–30 ml juice. (CCRAS.)
Taxonomic Cohort Genus Bryophyllum (1 documented species); Family Crassulaceae (5 documented species).

2. Classical Nomenclature, Taxonomy & Biogeographical Context

Bryophyllum pinnatum (taxonomically cited with authority (Lam.) Kurz.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Crassulaceae (primary family classification: Crassulaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. In classical and modern botanical literature, the species is cross-referenced under the botanical synonymy B. calycinum Salisb. Kalanchoe pinnata Pers, which is synchronized to prevent taxonomic ambiguity across regional herbal formularies. Biogeographically, its documented habitat and ecological distribution span: Throughout the warm and moist parts of India, especially abundant in West Bengal.

Across classical and vernacular Indian systems of medicine, Bryophyllum pinnatum is recognized under distinct polyglot nomenclature: in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Parnabija, Airaavati. (Also known as Paashaanabheda.); in the Unani-Tibb materia medica (recorded in The National Formulary of Unani Medicine and CCRUM literature) as Zakhm-e-Hayaat. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.

3. Therapeutic Actions, Phytochemistry & Pharmacological Profile

In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Bryophyllum pinnatum are: Leaf—disinfectant, antibacterial (used for boils, insect bites, swellings, burns, wounds). These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.

Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Bryophyllum pinnatum establish the following evidence base: Leaves, mixed with those of Aegle marmelos, are given in blood and amoebic dysentery. Leaves are also eaten to control diabetes. Leaves yield glycosides of quercetin and kaempferol, and fumaric acid. Plant extracts—antifungal.

image2

Botanical Reference 1: Kalanchoe pinnata — Botanical specimen

image3

Botanical Reference 2: Kalanchoe pinnata — Botanical specimen

image4

Botanical Reference 3: Bryophyllum pinnatum — Wikimedia Commons reference

4. Comparative Genus & Family Pharmacognosy

Within Indian medicinal flora, Bryophyllum pinnatum stands as a distinct representative of the genus Bryophyllum. Its therapeutic profile underscores the role of selectively utilized medicinal genera alongside larger polytypic genera.

At the family level, Crassulaceae encompasses 5 documented medicinal species (0.28% of the 1,814-species flora). Other representative medicinal members of Crassulaceae include: Kalanchoe integra (Parnabija), Kalanchoe laciniata (Parnabija), Kalanchoe pinnata (Parnabija), Sempervivum tectorum (Houseleek). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

image1

Figure 1: Quantitative documentation profile across all 5 medicinal species of family Crassulaceae.

5. Pharmacopoeial Standards, Posology & Reference Framework

For clinical and traditional dispensing, the standardized posology and crude herb dosage for Bryophyllum pinnatum are prescribed as follows: Leaf—10–30 ml juice. (CCRAS.). Crude drug dosages are calibrated against The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and the Standard Nomenclature of Ayurvedic Medicinal Plants published by the Central Council for Research in Ayurveda and Siddha (CCRAS). Classical and modern pharmacognostic synchronization for Bryophyllum pinnatum integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.

Scroll to Top